Clinical trials recruiting in Le Creusot, France

Phase breakdown

Conditions recruiting in Le Creusot, France

Recruiting trials in Le Creusot, France

• AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Maintain Their Weight Loss
  NCT07503210 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
  NCT07037433 · Phase: Phase 3 · Ages: 45 Years to 99 Years · Sex: All (male and female)
• Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
  NCT06677060 · Phase: Phase 3 · Ages: 40 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Le Creusot, France?

3 recruiting trials have at least one study site in Le Creusot, France.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.